Search
Alzamend Neuro Inc
ALZNAdd to Watchlist
1.940USD
0.0000.00%
Close 09-22 16:00（ET）
9.29MMarket Cap
LossP/E TTM
Alzamend Neuro Inc (ALZN) Stock Price Target & Forecast
Analyst Rating
Based on 1 analysts giving stock ratings to Alzamend Neuro Inc in the past month.
Buy
0 Strong Buy
1 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
26.000USD+1275.66%
ALZN Analyst Recommendation Trends
In the current month, ALZN has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ALZN average Analyst price target in the last month is 26.000.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
0
0
0
0
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
2
2
2
2
Financial Forecasting
Based on analysts' estimates, ALZN EPS is projected to reach -0.230 in FY2027Q2, following reported EPS of -0.676 in FY2027Q1. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q3
FY2026Q4
FY2027Q1
FY2027Q2
FY2027Q3
Forecast
-1.93
-0.67
-0.56
-0.23
-0.22
Actual
-0.58
-0.72
-0.68
--
--
Surprise
+69.98%
-7.56%
-20.69%
--
--
FAQs
What is Alzamend Neuro Inc's price target?
Analysts forecast that Alzamend Neuro Inc's price target is USD 42.00, with the highest forecast at USD 42.00 and the lowest forecast at USD 42.00.
How have Alzamend Neuro IncALZN's recent earnings per share performed?
The market expectation was USD -0.68, while Alzamend Neuro IncALZN's earnings per share (EPS) for the previous quarter was USD -0.72. EPS for the next quarter is expected at USD -0.23.
What is the analyst rating for Alzamend Neuro Inc?
Based on the ratings of Alzamend Neuro Inc's stock from 1 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.